InfuSystem Holdings Inc (INFU) Director Scott Shuda Purchases 23,406 Shares of Stock

Share on StockTwits

InfuSystem Holdings Inc (NYSEAMERICAN:INFU) Director Scott Shuda purchased 23,406 shares of InfuSystem stock in a transaction dated Friday, September 7th. The shares were acquired at an average cost of $3.24 per share, with a total value of $75,835.44. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Scott Shuda also recently made the following trade(s):

  • On Wednesday, September 5th, Scott Shuda purchased 9,548 shares of InfuSystem stock. The shares were acquired at an average cost of $3.23 per share, with a total value of $30,840.04.
  • On Thursday, August 30th, Scott Shuda purchased 72,479 shares of InfuSystem stock. The shares were acquired at an average cost of $3.16 per share, with a total value of $229,033.64.

Shares of NYSEAMERICAN INFU traded up $0.02 during midday trading on Friday, hitting $3.28. 17,369 shares of the company’s stock traded hands, compared to its average volume of 38,492. InfuSystem Holdings Inc has a 1 year low of $1.75 and a 1 year high of $3.60.

InfuSystem (NYSEAMERICAN:INFU) last released its quarterly earnings results on Tuesday, August 14th. The medical instruments supplier reported ($0.02) EPS for the quarter. InfuSystem had a negative net margin of 0.73% and a negative return on equity of 1.06%. The business had revenue of $16.42 million for the quarter.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in INFU. Renaissance Technologies LLC increased its position in shares of InfuSystem by 76.4% during the 2nd quarter. Renaissance Technologies LLC now owns 266,100 shares of the medical instruments supplier’s stock valued at $945,000 after purchasing an additional 115,236 shares during the last quarter. Minerva Advisors LLC increased its position in shares of InfuSystem by 3.4% during the 1st quarter. Minerva Advisors LLC now owns 2,126,064 shares of the medical instruments supplier’s stock valued at $6,165,000 after purchasing an additional 70,000 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in shares of InfuSystem by 30.2% during the 2nd quarter. Dimensional Fund Advisors LP now owns 172,199 shares of the medical instruments supplier’s stock valued at $611,000 after acquiring an additional 39,957 shares during the period. FineMark National Bank & Trust grew its stake in shares of InfuSystem by 12.0% during the 2nd quarter. FineMark National Bank & Trust now owns 255,575 shares of the medical instruments supplier’s stock valued at $907,000 after acquiring an additional 27,341 shares during the period. Finally, Gabelli Funds LLC grew its stake in shares of InfuSystem by 8.6% during the 2nd quarter. Gabelli Funds LLC now owns 280,000 shares of the medical instruments supplier’s stock valued at $994,000 after acquiring an additional 22,188 shares during the period.

About InfuSystem

InfuSystem Holdings Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.

Further Reading: Moving Average – How it Helps Investors in Stock Selection

Insider Buying and Selling by Quarter for InfuSystem (NYSEAMERICAN:INFU)

Receive News & Ratings for InfuSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InfuSystem and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply